Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,676.00
Bid: 1,676.00
Ask: 1,684.00
Change: 2.00 (0.12%)
Spread: 8.00 (0.477%)
Open: 1,670.00
High: 1,688.00
Low: 1,666.00
Prev. Close: 1,674.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Sep 2009 16:37

RNS Number : 8819Y
Genus PLC
10 September 2009
 



10 September 2009

FOR IMMEDIATE RELEASE 

Genus plc

('Genus' or 'the Company')

Director/PDMR Shareholding

Of 119,386 ordinary shares of 10 pence each in the Company ('Ordinary Shares') that vested today in favour of Richard Wood, Chief Executive, under the Company's Performance Share Plan (the 'Plan'), 60,290 Ordinary Shares are being retained by Richard Wood as part of his shareholding in the Company. 49,096 Ordinary Shares were today sold on behalf of Richard Wood at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Richard Wood as a result of today's vesting and a further 10,000 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Richard Wood.

Richard Wood's direct shareholding in the Company now stands at 120,595 Ordinary Shares which represent 0.203% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 223,710 conditional shares and nil-cost options under the Plan.

Of 68,220 Ordinary Shares that vested today in favour of Ian Biggs, Chief Operating Officer for the Americas, under the Plan, 26,777 Ordinary Shares are being retained by Ian Biggs as part of his shareholding in the Company. 28,055 Ordinary Shares were today sold on behalf of Ian Biggs at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Ian Biggs as a result of today's vesting and a further 13,388 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Ian Biggs.

Ian Biggs' direct shareholding in the Company now stands at 30,152 Ordinary Shares which represent 0.051of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 85,932 conditional shares and nil-cost options under the Plan.

Of 42,700 Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer for Europe and The Far East, under the Plan, 16,760 Ordinary Shares are being retained by Thomas Philip Acton as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Thomas Philip Acton as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Thomas Philip Acton.

Thomas Philip Acton's direct shareholding in the Company now stands at 37,864 Ordinary Shares which represent 0.064% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 78,627 conditional shares and nil-cost options under the Plan.

Of 42,700 Ordinary Shares that vested today in favour of Steve Amies, Chief Operating Officer for Global Research & Product Development, under the Plan, 16,760 Ordinary Shares are being retained by Steve Amies as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Steve Amies at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Steve Amies as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Steve Amies.

Steve Amies' direct shareholding in the Company now stands at 16,760 Ordinary Shares which represent 0.028% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 58,623 conditional shares and nil-cost options under the Plan.

 

For further information please contact:

 

Ian Farrelly Tel: 01256 345996

Group Company Secretary & General Counsel

Genus plc

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUROVRKBRKAAR
Date   Source Headline
9th Jun 20177:00 amRNSUS LITIGATION UPDATE
2nd Jun 20177:00 amRNSTotal Voting Rights
1st Jun 20177:05 amRNSUpdate Regarding The Milk Pension Fund
2nd May 20173:00 pmRNSTotal Voting Rights
12th Apr 20174:48 pmRNSDirector/PDMR Shareholding
3rd Apr 20172:00 pmRNSTotal Voting Rights
3rd Apr 20177:00 amRNSSUCCESSFUL LEGAL OUTCOME FOR GENUS
15th Mar 20175:15 pmRNSDirector/PDMR Shareholding
15th Mar 201712:00 pmRNSDirector Declaration
1st Mar 201710:09 amRNSDirector/PDMR Shareholding
23rd Feb 20174:20 pmRNSCorrection of Record Date
23rd Feb 20177:00 amRNSInterim Results
23rd Feb 20177:00 amRNSAcquisition and strategic partnership
7th Feb 20174:00 pmRNSHolding(s) in Company
1st Feb 20172:00 pmRNSBlock listing Interim Review
13th Dec 20163:39 pmRNSDirector/PDMR Shareholding
1st Dec 20162:00 pmRNSTotal Voting Rights
17th Nov 20162:01 pmRNSResult of AGM
17th Nov 20167:00 amRNSAGM - Trading Update
1st Nov 20164:00 pmRNSTotal Voting Rights
31st Oct 20163:47 pmRNSAnnual Report and Annual General Meeting
26th Oct 20164:00 pmRNSHolding(s) in Company
11th Oct 20164:08 pmRNSDirector/PDMR Shareholding
3rd Oct 20166:09 pmRNSBlock Listing and Additional Listing
3rd Oct 20165:57 pmRNSTotal Voting Rights
29th Sep 20165:00 pmRNSDirector/PDMR Shareholding
15th Sep 20165:00 pmRNSDirector/PDMR Shareholding
8th Sep 20165:18 pmRNSDirector/PDMR Shareholding
8th Sep 20167:00 amRNSPreliminary Results
7th Sep 20167:00 amRNSNON-EXECUTIVE DIRECTOR RETIREMENT
1st Sep 20164:17 pmRNSTotal Voting Rights
15th Aug 20167:00 amRNSFINAL JURY DECISIONS IN US LITIGATION
12th Aug 20167:00 amRNSFURTHER DECISIONS IN US LITIGATION
11th Aug 20167:00 amRNSFIRST DECISIONS IN US ANTI-TRUST LITIGATION
1st Aug 20169:20 amRNSBlock listing Interim Review
1st Aug 20169:09 amRNSTotal Voting Rights
27th Jul 20167:00 amRNSSigns exclusive licence for tech. to combat BRD
15th Jul 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Jul 20163:10 pmRNSTotal Voting Rights
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20162:00 pmRNSTotal Voting Rights
18th May 20167:00 amRNSExclusive Licence for Leading Gene Editing Tech
3rd May 20162:29 pmRNSTotal Voting Rights
13th Apr 20163:13 pmRNSDirector/PDMR Shareholding
1st Apr 20163:31 pmRNSDirector/PDMR Shareholding
9th Mar 20165:03 pmRNSDirector/PDMR Shareholding
4th Mar 20169:30 amRNSBOARD APPOINTMENT
3rd Mar 20162:00 pmRNSDirector/PDMR Shareholding
1st Mar 20165:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.